Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-16 @ 2:42 AM
Study NCT ID:
NCT02038920
Status:
COMPLETED
Last Update Posted:
2019-12-09
First Post:
2014-01-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-21
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-15
First Submit QC Date:
None
Study First Post Date:
2014-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-11-20
Results First Submit QC Date:
None
Results First Post Date:
2019-12-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-20
Last Update Post Date:
2019-12-09
Last Update Post Date Type:
ACTUAL